The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users
Open accessAbstract
Objectives To investigate the impact of harm‐reduction programmes on HIV and hepatitis C virus (HCV) incidence among ever‐injecting drug users (DU) from the Amsterdam Cohort Studies (ACS). Methods The association between use of harm reduction and seroconversion for human immunodeficiency virus (HIV) and/or hepatitis C virus (HCV) was evaluated using Poisson regression. A total of 714 DU were at risk for HIV and/or HCV during follow‐up. Harm reduction was measured by combining its two most important components—methadone dose and needle exchange programme (NEP) use—and looking at five categories of participation, ranging from no participation (no methadone in the past 6 months, injecting drug use in the past 6 months and no use of NEP) to full participation (≥ 60 mg methadone/day and no current injecting or ≥ 60 mg methadone/day and current injecting but all needles exchanged). Results Methadone dose or NEP use alone were not associated significantly with HIV or HCV seroconversion. However, with combination of these variables and after correction for possibly confounding variables, we found that full participation in a harm reduction programme (HRP) was associated with a lower risk of HIV and HCV infection in ever‐injecting drug users (DU), compared to no participation [incidence rate ratio 0.43 (95% CI 0.21–0.87) and 0.36 (95% CI 0.13–1.03), respectively]. Conclusions In conclusion, we found that full participation in HRP was associated with a lower incidence of HCV and HIV infection in ever‐injecting DU, indicating that combined prevention measures—but not the use of NEP or methadone alone—might contribute to the reduction of the spread of these infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amato, L., Davoli, M., A.Perucci, C., Ferri, M., Faggiano, F., & P. Mattick, R. (2005) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2005.02.007 · Cited by 567
Sharing of drug preparation equipment as a risk factor for hepatitis C
(2001) · American Journal of Public Health · doi:10.2105/ajph.91.1.42 · Cited by 500
Global overview of injecting drug use and HIV infection among injecting drug users
Aceijas, C., Stimson, G. V., Hickman, M., & Rhodes, T. (2004) · AIDS · doi:10.1097/00002030-200411190-00010 · Cited by 444
Wodak, A., & Cooney, A. (2006) · Substance Use & Misuse · doi:10.1080/10826080600669579 · Cited by 311
Implications of Methadone Maintenance for Theories of Narcotic Addiction
Dole, V. P. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410200081030 · Cited by 240
R. van den Hoek, J. A., Coutinho, R. A., van Haastrecht, H. J. A., van Zadelhoff, A. W., & Goudsmit, J. (1988) · AIDS · doi:10.1097/00002030-198802000-00010 · Cited by 197
Self-citationKroon, F. P., Rimmelzwaan, G. F., Roos, M. T. L., Osterhaus, A. D. M. E., Hamann, D., Miedema, F., & van Dissel, J. T. (1998) · AIDS · doi:10.1097/00002030-199817000-00002 · Cited by 175
Al-Jabri, A. A., McCloskey, D., Addawee, M., Bottazzo, F. G., Sachs, J., & OXFORD, J. S. (1998) · PubMed · Cited by 150
Sexual transmission of HCV between spouses.
Tahan, V., Karaca, C., Yildirim, B., Bozbas, A., Ozaras, R., Demir, K., Avsar, E., Mert, A., Besisik, F., Kaymakoglu, S., et al. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40879.x · Cited by 130
MacDonald, M., Kaldor, J. M., WODAK, A. D., Dolan, K. A., van Beek, I., & Cunningham, P. (2000) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2000.tb139199.x · Cited by 124
Research works printed but not linked: 5
- 10.1046/j.1360-0443.2000.95459110.x · doi:10.1046/j.1360-0443.2000.95459110.x
- 10.1097/01.aids.0000242824.59377.53 · doi:10.1097/01.aids.0000242824.59377.53
- 10.1080/09540120050123855 · doi:10.1080/09540120050123855
- 10.1093/ije/28.3.514 · doi:10.1093/ije/28.3.514
- 10.1016/S0140-6736(03)12831-0 · doi:10.1016/s0140-6736(03)12831-0
Cited by
Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Mathers, B. M., Degenhardt, L., Ali, H., Wiessing, L., Hickman, M., Mattick, R. P., Myers, B., Ambekar, A., & Strathdee, S. A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60232-2 · Cited by 717
Public health and international drug policy
Csete, J., Kamarulzaman, A., Kazatchkine, M., Altice, F., Balicki, M., Buxton, J., Cepeda, J., Comfort, M., Goosby, E., Goulão, J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00619-x · Cited by 641
HIV and risk environment for injecting drug users: the past, present, and future
Strathdee, S. A., Hallett, T. B., Bobrova, N., Rhodes, T., Booth, R., Abdool, R., & Hankins, C. A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60743-x · Cited by 559
MacArthur, G. J., Minozzi, S., Martin, N., Vickerman, P., Deren, S., Bruneau, J., Degenhardt, L., & Hickman, M. (2012) · BMJ · doi:10.1136/bmj.e5945 · Cited by 410
Metadata
- Authors
- Van Den Berg, C., Smit, C., Van Brussel, G., Coutinho, R., & Prins, M.
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2007-08-09
- Volume
- 102
- Issue
- 9
- Pages
- 1454-1462
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W2164227241
- Cited by
- 316
- References
- 19
- FWCI
- 13.82
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users. https://app.cochat.ai/papers/10.1111/j.1360-0443.2007.01912.x
- The paper
- Van Den Berg, C., Smit, C., Van Brussel, G., Coutinho, R., & Prins, M. (2007). Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users. Addiction. https://doi.org/10.1111/j.1360-0443.2007.01912.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
